---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-006446"
form_type: "8-K"
ticker: "ERNA"
cik: "0000748592"
company_name: "Ernexa Therapeutics Inc."
filed_at: "2025-02-13T23:59:59+00:00"
generated_at: "2026-05-26T22:36:59.373712+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Eterna Therapeutics sets 2025 annual meeting for May 1; shareholder proposals due Feb 23

## Summary
- Annual meeting date: May 1, 2025; over 30 days before one-year anniversary of 2024 meeting.
- Stockholder proposals and director nominations must be received by Feb 23, 2025.
- Rule 14a-8 proposals also due Feb 23, 2025; submissions to Cambridge, MA office.

## SEC filing metadata
- accession: 0001493152-25-006446
- form_type: 8-K
- ticker: ERNA
- cik: 0000748592
- company_name: Ernexa Therapeutics Inc.
- filed_at: 2025-02-13T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.08
- EDGAR index: https://www.sec.gov/Archives/edgar/data/748592/000149315225006446/0001493152-25-006446-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/748592/000149315225006446/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-006446
- JSON: https://secwatch.observer/filing/0001493152-25-006446.json
- Plain text: https://secwatch.observer/filing/0001493152-25-006446.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.